336 related articles for article (PubMed ID: 33779080)
1. Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases.
Castelino FV; Moua T
ACR Open Rheumatol; 2021 May; 3(5):295-304. PubMed ID: 33779080
[TBL] [Abstract][Full Text] [Related]
2. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
3. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
Fischer A; Distler J
Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).
Spagnolo P; Distler O; Ryerson CJ; Tzouvelekis A; Lee JS; Bonella F; Bouros D; Hoffmann-Vold AM; Crestani B; Matteson EL
Ann Rheum Dis; 2021 Feb; 80(2):143-150. PubMed ID: 33037004
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications.
Erre GL; Sebastiani M; Manfredi A; Gerratana E; Atzeni F; Passiu G; Mangoni AA
Drugs Context; 2021; 10():. PubMed ID: 33505482
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Yoo H; Hino T; Hwang J; Franks TJ; Han J; Im Y; Lee HY; Chung MP; Hatabu H; Lee KS
Eur J Radiol Open; 2022; 9():100419. PubMed ID: 35445144
[TBL] [Abstract][Full Text] [Related]
7. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
8. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
9. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
10. Role of High-Resolution CT Thorax in Diagnosing Interstitial Lung Disease and Its Association With Smoking and Connective Tissue Disorder.
Doshi JA; Mundhra KS; Shah DS; Shah SN; Patel TV; Bhatt A
Cureus; 2022 Nov; 14(11):e31107. PubMed ID: 36475156
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Yoo H; Hino T; Han J; Franks TJ; Im Y; Hatabu H; Chung MP; Lee KS
Eur J Radiol Open; 2021; 8():100311. PubMed ID: 33364263
[TBL] [Abstract][Full Text] [Related]
12. The natural history of progressive fibrosing interstitial lung diseases.
Kolb M; Vašáková M
Respir Res; 2019 Mar; 20(1):57. PubMed ID: 30871560
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases.
Koslow M; Maleki-Fischbach M; Keith RC
Case Rep Rheumatol; 2021; 2021():6677353. PubMed ID: 33986967
[TBL] [Abstract][Full Text] [Related]
14. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
[TBL] [Abstract][Full Text] [Related]
15. Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis.
Khanna SA; Nance JW; Suliman SA
Curr Rheumatol Rep; 2022 May; 24(5):166-173. PubMed ID: 35499699
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline.
Nagy A; Nagy T; Kolonics-Farkas AM; Eszes N; Vincze K; Barczi E; Tarnoki AD; Tarnoki DL; Nagy G; Kiss E; Maurovich-Horvat P; Bohacs A; Müller V
Front Pharmacol; 2021; 12():778649. PubMed ID: 35002713
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
18. Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease.
Schmid U; Weber B; Magnusson MO; Freiwald M
Respir Med; 2021; 180():106369. PubMed ID: 33798871
[TBL] [Abstract][Full Text] [Related]
19. Management of Fibrosing Interstitial Lung Diseases.
Maher TM; Wuyts W
Adv Ther; 2019 Jul; 36(7):1518-1531. PubMed ID: 31119691
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease.
Tolle LB
Case Rep Pulmonol; 2022; 2022():9942432. PubMed ID: 35211349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
